Septerna, Inc. (SEPN)
24.08
+0.74
(+3.15%)
USD |
NASDAQ |
Apr 14, 16:00
24.08
0.00 (0.00%)
After-Hours: 19:45
Septerna EPS Diluted (Quarterly) : -0.2409 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Bristol Myers Squibb Co. | 0.5326 |
| Moderna, Inc. | -2.107 |
| Halozyme Therapeutics, Inc. | -1.203 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.74M |
| Revenue (Quarterly) | 24.12M |
| Total Expenses (Quarterly) | 34.86M |
| Enterprise Value | 680.65M |
| Gross Profit Margin (Quarterly) | 98.34% |
| Profit Margin (Quarterly) | -44.52% |
| Earnings Yield | -4.62% |
| Normalized Earnings Yield | -4.622 |